AS Responds Better than AxSpA to Infliximab (CME/CE)

(MedPage Today) -- ASAS partial remission rate of 70% in AS patients
Source: MedPage Today Geriatrics - Category: Geriatrics Source Type: news
More News: Geriatrics | Remicade